PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

33,546 stories, page 2 of 560

Advanced search
🌍discoverynews.google.com

AI is changing the talent biotech companies compete to hire

BioSpaceOriginal source
🌍Researchunmc.edu

UNMC brings AI expertise to $6 million NSF crop resilience project

UNMCOriginal source
🇪🇸Researchclinicbarcelona.org

More than 1,500 patients have taken part in the Clínic Prehabilitation Program

Hospital Clínic de BarcelonaOriginal source
🌍Researchunmc.edu

DeCarolis named director of Sponsored Programs Administration

UNMCOriginal source
🌍Researchunmc.edu

Center for Healthy Living hosts open house through Sept. 24

UNMCOriginal source
🌍Researchunmc.edu

CHRI events examine advances in pediatric cancer, brain tumor research

UNMCOriginal source
🌍discoverynews.google.com

CRB-913 Obesity Drug Shows 5% Weight Loss in Phase 1b Trial

The Clinical Trial VanguardOriginal source
🌍discoverynews.google.com

TRUTAKNA Meets All Endpoints in Phase 3 IgA Nephropathy Trial Final Analysis

The Clinical Trial VanguardOriginal source
🇯🇵Industrychugai-pharm.co.jp

FoundationOne CDx がんゲノムプロファイル、BRAF V600変異及びBRAF融合遺伝子陽性の神経膠腫に対するトボラフェニブのコンパニオン診断として承認を取得

Chugai Pharmaceutical NewsOriginal source
🇯🇵Industrychugai-pharm.co.jp

Chugai Obtains Approval for FoundationOne CDx Cancer Genomic Profile as a Companion Diagnostic of Tovorafenib for BRAF V600 Alterations and BRAF Fusion Gene-Positive Glioma

Chugai PharmaceuticalOriginal source
🌍discoverynews.google.com

Zymfentra, Xcopri projected to become Korea’s 1st $1 billion blockbuster drugs in 2027

Korea Biomedical ReviewOriginal source
🌍Industryavacta.com

Avacta Achieves Clinical Proof of Mechanism for the Next Generation of pre|CISION® Medicines with AVA6103 (FAP-Exd) in the Phase 1 FOCUS-01 Trial

Avacta GroupOriginal source
🇸🇪Researchvgrfokus.se

Så har VGR byggt en modell för specialistläkares fortbildning

Sahlgrenska SwedenOriginal source
🇨🇭Researchusz.ch

Von der Krebsdiagnose ins Olympische Dorf

Universitätsspital Zürich (USZ)Original source
🌍discoverynews.google.com

Legend Biotech names new CEO

thebambooworks.comOriginal source
🌍discoverynews.google.com

Biotech Stocks At 52-Week Highs - MNOV +8%, RVTY +8%, TXG +6%, TLX +9%, SDGR +12%

RTTNewsOriginal source
🌍discoverynews.google.com

DengiAll: India's first indigenous dengue vaccine could arrive by 2027

FirstpostOriginal source
🌍discoverynews.google.com

Teva Pharmaceutical Industries (TEVA) Starts Direct NYSE Share Trading In Shift From ADS

simplywall.stOriginal source
🌍discoverynews.google.com

Takeda Pharmaceutical (TAK) Insider Sale: Chief Transformation O

GuruFocusOriginal source
🇺🇸Researchonlinelibrary.wiley.com

Left Ventricular Pacing‐Associated Cardiomyopathy Revealing Myocardial Vulnerability in Congenital Complete Heart Block

Pacing and Clinical ElectrophysiologyOriginal source
🌍Associationkff.org

Global COVID-19 Tracker

KFF (Kaiser Family Foundation) HealthOriginal source
🇺🇸Researchonlinelibrary.wiley.com

Leadless Pacemaker Implant Location as a Predictor of Pacing Induced Cardiomyopathy

Pacing and Clinical ElectrophysiologyOriginal source
🇺🇸Researchonlinelibrary.wiley.com

Alternating VA Intervals, What is the Mechanism?

Pacing and Clinical ElectrophysiologyOriginal source
🌍discoverynews.google.com

Führendes Biotech-Unternehmen entscheidet sich weltweit für Veeva Vault CRM

PR NewswireOriginal source
🌍discoverynews.google.com

ETFs Investing in Hangzhou Biotest Biotech Co., Ltd. Class A Stocks

TradingViewOriginal source
🌍discoverynews.google.com

FDA suspends licences of Mumbai's iconic Cafe Mondegar, 3 other eateries

RediffOriginal source
🌍discoverynews.google.com

3 Clinical-Stage Cancer Stocks With Pristine Balance Sheets

simplywall.stOriginal source
🌍discoverynews.google.com

Pharmosa Biopharm's Inhaled Drug L606 Wins China Approval to Launch Global Phase 3 Trial for Pulmonary Hypertension

finance.biggo.comOriginal source
🌍discoverynews.google.com

Tenax Therapeutics CEO Christopher Giordano acquires $20,087 in shares

Investing.comOriginal source
🌍discoverynews.google.com

US approves world’s first drug to treat muscle atrophy in SMA

Новости GxPOriginal source
🌍discoverynews.google.com

Cambium Bio raises $5M to fund pivotal Phase 3 eye disease trial

DealroomOriginal source
🌍discoverynews.google.com

ETFs Investing in Guanhao Biotech Co., Ltd. Class A Stocks

TradingViewOriginal source
🌍Researchunlp.edu.ar

A 50 años, los Lápices siguen escribiendo y son Honoris Causa de la UNLP

UNLP Health SciencesOriginal source
🌍Researchunlp.edu.ar

A 50 años de su asesinato, rendimos homenaje a Sergio Karakachoff

UNLP Health SciencesOriginal source
🌍Researchunlp.edu.ar

Distinguiremos con el Doctorado Honoris Causa a los militantes estudiantiles de La Noche de los Lápices

UNLP Health SciencesOriginal source
🌍Regulatorypharmac.govt.nz

Pharmac seeks feedback on widening access to febuxostat for people with gout

Pharmac New ZealandOriginal source
🌍discoverynews.google.com

Legend Biotech taps Novartis veteran Zhang as CEO

pharma.economictimes.indiatimes.comOriginal source
🌍discoverynews.google.com

Biotech Midweek Pulse: XBI Loses Steam After Hot 2026 Run — Here Are The Stocks And Catalysts To Watch Next

TradingViewOriginal source
🌍discoverynews.google.com

Biotech Midweek Pulse: XBI Loses Steam After Hot 2026 Run — Here Are The Stocks And Catalysts To Watch Next

finance.yahoo.comOriginal source
🌍Researchhelsinki.fi

Active Numeracy Welcomes Colleagues from Tallinn University

Helsinki University ResearchOriginal source
🇺🇸Researchsciencedaily.com

Scientists reversed biological age in older adults in just 4 weeks

ScienceDaily Health RSSOriginal source
🌍discoverynews.google.com

Perriello discusses biotech's future with local leaders

cbs19news.comOriginal source
🌍discoverynews.google.com

Vera Says Phase 3 Trutakna Trial Slowed IgA Nephropathy Progression

findarticles.comOriginal source
🌍discoverynews.google.com

Pharmaceutical Executive Survey Finds Emerging Biotech CEOs Increasingly Rely on External Advisors

geneonline.comOriginal source
🌍discoverynews.google.com

Legend Biotech taps Novartis veteran Zhang as CEO

KSL.comOriginal source
🇯🇵Industryotsukakj.jp

EN Otsuka Pharmaceutical Obtains Marketing Approval for ENOFEED® Liquid for Enteral Use

Otsuka Holdings RSSOriginal source
🌍Researchnature.com

Local antibody-driven response to anti-PD-1 blockade

Nature CancerOriginal source
🇬🇧Researchnature.com

EBV reactivation priming of the peripheral immune system in multiple sclerosis relapse

Nature MedicineOriginal source
🇬🇧Researchnature.com

Sex-specific biological aging clocks across organs and omics

Nature MedicineOriginal source
🇬🇧Researchnature.com

Factor IX Padua AAV gene therapy in adolescents with hemophilia B: a phase 1 trial

Nature MedicineOriginal source
🇬🇧Researchnature.com

Liquid biopsy for early detection of pancreatic ductal adenocarcinoma

Nature MedicineOriginal source
🇬🇧Researchnature.com

Map of brain ‘microproteins’ could offer new clues to Alzheimer’s disease

NatureOriginal source
🇬🇧Researchnature.com

AI companies must work with the research community to protect attribution

NatureOriginal source
🇬🇧Researchnature.com

These bizarre, much-coveted microbes are revealing the origins of complex life

NatureOriginal source
🇮🇳Industrynatcopharma.co.in

natco records %e2%82%b9816 9 crore consolidated revenue and %e2%82%b9269 0 crore of profit after tax for q4 fy26 and %e2%82%b94375 9 crore of revenue %e2%82%b91418 5 crore profit after tax for fy26

Natco PharmaOriginal source
🇮🇳Industrynatcopharma.co.in

natco records %e2%82%b9794 4 crore consolidated revenue and %e2%82%b9206 5 crore of profit after tax for q1 fy27

Natco PharmaOriginal source
🇮🇳Industrynatcopharma.co.in

natco records %e2%82%b9705 4 crore consolidated revenue and %e2%82%b9151 3 crore of profit after tax for q3fy26

Natco PharmaOriginal source
🇮🇳Industrynatcopharma.co.in

natco receives tentative approval for olaparib tablets from the united states food and drug administration u s fda

Natco PharmaOriginal source
🇮🇳Industrynatcopharma.co.in

natco receives approval from central drug standard control organisation cdsco for semaglutide in india

Natco PharmaOriginal source
🇮🇳Industrynatcopharma.co.in

natco pharma limited gets approval from its board of directors for increasing its stake in adcock ingram holdings proprietary limited to 49

Natco PharmaOriginal source